教育背景

2005年9月-2010年6月：武汉大学临床医学专业本科

2010年9月-2013年6月：复旦大学免疫学专业硕士

2018年9月-2021年12月：复旦大学病原生物学专业博士

研究方向

新发突发病毒的感染机制及抗病毒药物和疫苗的研究

1: Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y,

Lu L, Jiang S, Wang Q. A highly potent and stable pan-coronavirus fusion

inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other

coronavirus diseases. Acta Pharm Sin B. 2022 Apr;12(4):1652-1661. doi:

10.1016/j.apsb.2021.07.026. Epub 2021 Aug 2. PMID: 34367893; PMCID: PMC8327648.

2: Lan Q, Pu J, Cai Y, Zhou J, Wang L, Jiao F, Xu W, Wang Q, Xia S, Lu L, Jiang

S. Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection.

Microbes Infect. 2021 Sep-Oct;23(8):104840. doi: 10.1016/j.micinf.2021.104840.

Epub 2021 May 20. PMID: 34022374; PMCID: PMC8133820.

3: Cai Y, Xu W, Tang J, Cao N, Lan Q, Lu L, Jiang S. A bivalent protein

targeting glycans and HR1 domain in spike protein potently inhibited infection

of SARS-CoV-2 and other human coronaviruses. Cell Biosci. 2021 Jul 8;11(1):128.

doi: 10.1186/s13578-021-00638-w. PMID: 34238357; PMCID: PMC8264481.

4: Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S.

25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum

Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human

Coronaviruses. Int J Mol Sci. 2021 Nov 1;22(21):11869. doi:

10.3390/ijms222111869. PMID: 34769299; PMCID: PMC8584349.

5: Shen H, Cai Y, Zhang H, Wu J, Ye L, Yang P, Lin X, Jiang S, Liao M. Anti-

SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-

CoV-2 for Immunoprophylaxis of COVID-19. Virol Sin. 2021 Oct;36(5):1080-1082.

doi: 10.1007/s12250-021-00371-1. Epub 2021 May 21. PMID: 34019233; PMCID:

PMC8137804.

6: Cai Y, Xu W, Gu C, Cai X, Qu D, Lu L, Xie Y, Jiang S. Griffithsin with A

Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein

Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion

Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit. Virol Sin. 2020

Dec;35(6):857-860. doi: 10.1007/s12250-020-00305-3. Epub 2020 Oct 14. PMID:

33052520; PMCID: PMC7554295.

无